|
|
Volumn 514, Issue 2-3, 2002, Pages 250-254
|
|
Farnesylpyridinium, an analog of isoprenoid farnesol, induces apoptosis but suppresses apoptotic body formation in human promyelocytic leukemia cells
a
a
a
a
a
|
|
Author keywords
Actin; Apoptosis; Apoptotic body; Farnesol; HL 60 cells
|
|
Indexed keywords
1 FARNESYLPYRIDINIUM;
ANISOMYCIN;
CYTOCHALASIN;
CYTOCHROME C;
DACTINOMYCIN;
DNA FRAGMENT;
FARNESOL;
UNCLASSIFIED DRUG;
ACTIN FILAMENT;
APOPTOSIS;
ARTICLE;
CELL DEATH;
CELL PROTECTION;
CELL STRUCTURE;
CONTROLLED STUDY;
CYTOPLASM;
DOSE RESPONSE;
DRUG EFFECT;
HUMAN;
HUMAN CELL;
LEUKEMIA CELL;
MICROFILAMENT;
PRIORITY JOURNAL;
PROMYELOCYTIC LEUKEMIA;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CASPASES;
CYSTEINE PROTEINASE INHIBITORS;
CYTOCHALASIN B;
DNA;
DNA FRAGMENTATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG EVALUATION, PRECLINICAL;
FARNESOL;
HL-60 CELLS;
HUMANS;
INCLUSION BODIES;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
MICROFILAMENTS;
MITOCHONDRIA;
NUCLEIC ACID SYNTHESIS INHIBITORS;
PROTEIN SYNTHESIS INHIBITORS;
PYRIDINIUM COMPOUNDS;
SESQUITERPENES;
|
|
EID: 0037070604
PISSN: 00145793
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-5793(02)02373-6 Document Type: Article |
|
Times cited : (9)
|
|
References (36)
|
